Research Article
N6-Methyladenosine (m6A)-Related lncRNAs Are Potential Signatures for Predicting Prognosis and Immune Response in Lung Squamous Cell Carcinoma
Figure 4
Evaluation of the risk model of the m6A-related lncRNAs. (a) Multivariate prognostic analysis of risk score and clinical characteristic. (b) Univariate prognostic analysis of risk score and clinical characteristic. (c) ROC curves of risk score and clinical characteristics. (d) C-index of risk score and clinical characteristic. (e)-(f) Nomogram and calibration curve predicted the overall survival of 1-year, 3-year, and 5-year grounded on gender, age, TNM, and risk score (Example: female, 69 years old, stage II, T2M0N1, high risk). Application of risk model for tumor immune-related analysis.
| (a) |
| (b) |
| (c) |
| (d) |
| (e) |
| (f) |